Document Detail

A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension.
MedLine Citation:
PMID:  15615808     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Loop diuretics are the drugs of choice for the treatment of hypertension in chronic renal failure patients. However, the adaptive changes in the distal nephron and the short half-life of these drugs may decrease their long-term efficacy. Thiazides are not believed to be efficient in advanced renal failure, but this is debated. METHODS: We compared the efficacy of long-acting furosemide (60 mg/day) and hydrochlorothiazide (25 mg/day) in a double-blind, randomized crossover trial in seven patients with severe renal failure and hypertension (seven men, 54+/-10 years old). The primary end-points were sodium and chloride fractional excretions after 1 month of each diuretic and then after their combination. During the trial, other treatments and the diet were controlled. RESULTS: A trend towards an increase in the fractional excretion of sodium and of chloride was observed with furosemide, but the difference did not reach the level of statistical significance (P = NS). Hydrochlorothiazide significantly increased fractional excretion of sodium and chloride from 3.7+/-0.9 to 5.5+/-0.3 and from 3.9+/-0.19 to 6.5+/-0.3, respectively (P<0.05). The combination of the two diuretics had no additional effect on the increase in sodium and chloride fractional excretion. Furosemide, hydrochlorothiazide and the combination of the two diuretics decreased mean arterial blood pressure by the same extent from 112 to 97, 99 and 97 mmHg, respectively (P<0.05). CONCLUSIONS: Hydrochlorothiazide increased the fractional excretion of sodium and chloride more than furosemide did in hypertensive severe renal failure patients. Mean arterial blood pressure decreased by the same amount with both diuretics. Combining furosemide and hydrochlorothiazide did not increase the efficacy of hydrochlorothiazide.
Bertrand Dussol; Julie Moussi-Frances; Sophie Morange; Claude Somma-Delpero; Olivier Mundler; Yvon Berland
Related Documents :
20713328 - Blood gas values and pulmonary hypertension as affected by dietary sodium source in bro...
12397268 - Carbohydrate-electrolyte rehydration protects against intravascular volume contraction ...
396248 - Changes in renal vascular sensitivity and arterial pressure associated with sodium inta...
8281528 - Effects of nitrendipine and lisinopril on blood pressure and sodium excretion in ciclos...
17679828 - Prehypertension and the cardiometabolic syndrome: is there any value in pharmacologic i...
11110768 - Current perspectives on the use of gene therapy for hypertension.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2004-12-22
Journal Detail:
Title:  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association     Volume:  20     ISSN:  0931-0509     ISO Abbreviation:  Nephrol. Dial. Transplant.     Publication Date:  2005 Feb 
Date Detail:
Created Date:  2005-01-27     Completed Date:  2005-05-12     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8706402     Medline TA:  Nephrol Dial Transplant     Country:  England    
Other Details:
Languages:  eng     Pagination:  349-53     Citation Subset:  IM    
Service de Néphrologie-Hémodialyse-Transplantation, Hôpital de la Conception, 147 Bd Baille, 13385 Marseille Cedex 5, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Chlorides / urine
Cross-Over Studies
Double-Blind Method
Furosemide / therapeutic use*
Hydrochlorothiazide / therapeutic use*
Hypertension / drug therapy*,  etiology
Kidney Failure, Chronic / physiopathology*
Middle Aged
Sodium / urine
Sodium Chloride Symporter Inhibitors / therapeutic use
Reg. No./Substance:
0/Chlorides; 0/Diuretics; 0/Sodium Chloride Symporter Inhibitors; 54-31-9/Furosemide; 58-93-5/Hydrochlorothiazide; 7440-23-5/Sodium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Left bundle branch block induces ventricular remodelling and functional septal hypoperfusion.
Next Document:  Short-term treatment with rosiglitazone improves glucose tolerance, insulin sensitivity and endothel...